Other Event

Other Event

Other Adverse Events are non-serious adverse events that exceed a specific frequency threshold (typically 5% within any study arm). These events are reported to provide comprehensive safety information about all noteworthy adverse occurrences during clinical trials. Each other event is categorized by term, organ system, assessment type, and source vocabulary for standardized reporting.

Other Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Other Event

Study -> Results Section -> Adverse Events Module -> Other Event -> Other Event Stats

Other Event


Ignite Creation Date: 2025-12-24 @ 3:19 PM
Ignite Modification Date: 2025-12-25 @ 1:39 PM
NCT ID: NCT01697592
Term: Nasopharyngitis
Organ System: Infections and infestations
Assessment Type: SYSTEMATIC_ASSESSMENT
Source Vocabulary: MedDRA 17.0
Notes: None
Study: NCT01697592
Study Brief: Omarigliptin (MK-3102) Clinical Trial - Add-on to Oral Antihyperglycemic Agent Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-3102-015)
Other Event Stats (If Any):

Other Event Stats

Group ID # Events # Affected # At Risk View
EG000 17 15 126 View
EG001 16 14 65 View
EG002 14 11 66 View
EG003 13 11 65 View
EG004 14 13 67 View
EG005 49 44 196 View
EG006 44 34 126 View
EG007 30 23 65 View
EG008 34 24 66 View
EG009 29 19 65 View
EG010 25 19 67 View
EG011 44 36 191 View